tm
Seeing Is Believing
tm
Seeing Is Believing
Leap Therapeutics's activity chart (see below) currently has 7 price targets and 12 ratings on display.
Analysts average stock forecasts to be materialized ratio is 36.67% with an average time for these price targets to be met of 304.2 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 27-Mar-2025. First documented stock forecast 07-Mar-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 27-Mar-2025
1 years 5 months 20 days ago
(27-Mar-2025)
0/6 (0%)
$2.92 (113.18%)
Buy Since 03-Jun-2021
$9
$6.95 (339.02%)
2 years 5 months 28 days ago
(19-Mar-2024)
0/2 (0%)
$6.8 (309.09%)
Buy Since 17-May-2021
2 years 5 months 29 days ago
(18-Mar-2024)
1/3 (33.33%)
$28.9 (260.36%)
669
Buy Since 05-Oct-2021
2 years 9 months 27 days ago
(20-Nov-2023)
1/3 (33.33%)
$-23.1 (-79.38%)
382
Buy Since 05-Apr-2022
2 years 10 months 2 days ago
(14-Nov-2023)
0/2 (0%)
$13.21 (348.55%)
What is LPTX (Leap Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on LPTX (Leap Therapeutics)?
Which analyst has the most public recommendations on LPTX (Leap Therapeutics)?
Which analyst is the currently most bullish on LPTX (Leap Therapeutics)?
Which analyst is the currently most reserved on LPTX (Leap Therapeutics)?
